Andrea Gropman (@andreagropman) 's Twitter Profile
Andrea Gropman

@andreagropman

Director, Neurometabolic Translational Research, St. Jude Children's Research Hospital, Brain imager, Screen play writer, Author, mom of former Team USA skater

ID: 2435907699

calendar_today25-03-2014 15:28:48

170 Tweet

571 Followers

704 Following

Andrea Gropman (@andreagropman) 's Twitter Profile Photo

It’s really important to have all stakeholders in the same room. Thanks for hosting and including our UCDC and NUCDF partners

Andrea Gropman (@andreagropman) 's Twitter Profile Photo

Great Neurogenetics SIG at ANA: Beyond the mouse:The future of preclinical trials in Neurogenetic Disease. Thanks to the speakers and my co chair, Gemma Carvill

Great Neurogenetics SIG at ANA: Beyond the mouse:The future of preclinical trials in Neurogenetic Disease. Thanks to the speakers and my co chair, Gemma Carvill
Andrea Gropman (@andreagropman) 's Twitter Profile Photo

Proud of this young man with a rare metabolic disease. He is living his best life. I was privileged to care for him for 15 years. The field has come a long way but still looking for a cure.

Proud of this young man with a rare metabolic disease. He is living his best life. I was privileged to care for him for 15 years. The field has come a long way but still looking for a cure.
Andrea Gropman (@andreagropman) 's Twitter Profile Photo

Hi fellow Neurogeneticists and those interested in NG and future of the field, our NG SIG at the CNSAM is November 13th, 6:00 pm - 7:00 pm Marina Kitchen PDR Child Neurology Society St. Jude Research

Child Neurology Foundation (@child_neurology) 's Twitter Profile Photo

Rare isn’t rare in child neurology. Half of the 30M+ people with a rare disease are children, and many remain undiagnosed. On #RAREDiseaseDay, CNF strengthens the systems that support these families. Awareness is just the start—action makes the difference. 💜 #CNFCommunity

Rare isn’t rare in child neurology. Half of the 30M+ people with a rare disease are children, and many remain undiagnosed. On #RAREDiseaseDay, CNF strengthens the systems that support these families. Awareness is just the start—action makes the difference. 💜 #CNFCommunity
Catherine Stratton, MPH (@cathsmstratton) 's Twitter Profile Photo

It’s #RareDiseaseDay! With ~1 in 12 affected, RDs represent a significant healthcare burden. The RD diagnostic odyssey is a call for improved RD awareness. The fact that still, only 5% of RDs have a therapy is a sobering reminder of the work we have to do. #RareDiseaseIsNotRare

Andrea Gropman (@andreagropman) 's Twitter Profile Photo

It was an honor to be part of #RareDiseaseDay2025 at #seattlechildren’s and #PacificNorwestResearchInstitute to recount our incredible journey with #NUCDF as we find cures for #ureacycledisorders #UCDC

Andrea Gropman (@andreagropman) 's Twitter Profile Photo

It was an honor working on this latest addition with great editors and authors. Check out the new chapter videos and many new, junior faculty authors.

It was an honor working on this latest addition with great editors and authors. Check out the new chapter videos and many new, junior faculty authors.
Andrea Gropman (@andreagropman) 's Twitter Profile Photo

Congratulations Maria Jose on publication of your paper based on your MPH thesis. It was an honor to be part of your thesis committee. Assessing Environmental Justice in Mexico: How Polluting Industries and Healthcare Disparities Impact Congenital He… pubmed.ncbi.nlm.nih.gov/40079194/

Neurology Journal (@greenjournal) 's Twitter Profile Photo

Neurology Podcast: Dr. Andrea Gropman and Dr. Stefan Pulst discuss the significant advancements in Neurology® Genetics over the past decade. Listen now: hubs.la/Q03dL-RH0 #NeuroTwitter #NeuroGenetics Andrea Gropman

NEJM (@nejm) 's Twitter Profile Photo

In a new editorial, Andrea Gropman, MD, and Alexis C. Komor, PhD (Komor Lab), describe the foundations of an N-of-1 gene-editing study to treat an infant with a urea-cycle disorder. Read the editorial: nej.md/430hLWR #ASGCT2025 | ASGCT

In a new editorial, <a href="/AndreaGropman/">Andrea Gropman</a>, MD, and Alexis C. Komor, PhD (<a href="/KomorLab/">Komor Lab</a>), describe the foundations of an N-of-1 gene-editing study to treat an infant with a urea-cycle disorder. Read the editorial: nej.md/430hLWR 

#ASGCT2025 | <a href="/ASGCTherapy/">ASGCT</a>